Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Net Margin (2016 - 2025)

Historic Net Margin for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 24.12%.

  • Medifast's Net Margin fell 247900.0% to 24.12% in Q4 2025 from the same period last year, while for Dec 2025 it was 4.84%, marking a year-over-year decrease of 51800.0%. This contributed to the annual value of 4.84% for FY2025, which is 51900.0% down from last year.
  • Medifast's Net Margin amounted to 24.12% in Q4 2025, which was down 247900.0% from 2.52% recorded in Q3 2025.
  • Medifast's Net Margin's 5-year high stood at 12.05% during Q1 2021, with a 5-year trough of 24.12% in Q4 2025.
  • Its 5-year average for Net Margin is 4.5%, with a median of 8.25% in 2022.
  • Over the last 5 years, Medifast's Net Margin had its largest YoY gain of 71800bps in 2025, and its largest YoY loss of -247900bps in 2025.
  • Over the past 5 years, Medifast's Net Margin (Quarter) stood at 9.0% in 2021, then decreased by -13bps to 7.86% in 2022, then crashed by -60bps to 3.16% in 2023, then crashed by -79bps to 0.67% in 2024, then plummeted by -3702bps to 24.12% in 2025.
  • Its Net Margin was 24.12% in Q4 2025, compared to 2.52% in Q3 2025 and 2.34% in Q2 2025.